Trial intelligence / Profile preview

Intra-articular tranexamic acid added to intravenous tranexamic acid in unilateral total knee arthroplasty

2013-003169-33Phase 4Completed

Sponsor
Anders Troelsen
Start
Oct 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in knee osteoarthritis (OA) comparing IV tranexamic acid + intra-articular tranexamic acid with IV tranexamic acid + intra-articular placebo (2 arms). Primary endpoint: Total blood loss at 24 hours. Started Oct 2013; status: completed.

02

Drugs

tranexamic acid
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on 2013-003169-33.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-003169-33.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call